TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $354 | -99.9% | 42,363 | +234.5% | 0.01% | +60.0% |
Q4 2021 | $241,000 | -43.0% | 12,666 | -0.4% | 0.01% | -44.4% |
Q3 2021 | $423,000 | +386.2% | 12,716 | +27.2% | 0.01% | +350.0% |
Q2 2019 | $87,000 | -28.1% | 10,000 | -33.3% | 0.00% | -33.3% |
Q1 2019 | $121,000 | -13.6% | 15,000 | -50.0% | 0.00% | -57.1% |
Q4 2016 | $140,000 | -39.7% | 30,000 | 0.0% | 0.01% | -50.0% |
Q3 2016 | $232,000 | +25.4% | 30,000 | -2.0% | 0.01% | 0.0% |
Q2 2016 | $185,000 | -57.5% | 30,600 | -40.0% | 0.01% | -26.3% |
Q1 2016 | $435,000 | -28.5% | 51,000 | 0.0% | 0.02% | -54.8% |
Q4 2015 | $608,000 | +18.3% | 51,000 | 0.0% | 0.04% | +82.6% |
Q3 2015 | $514,000 | +3.2% | 51,000 | +70.0% | 0.02% | +15.0% |
Q2 2015 | $498,000 | -19.5% | 30,000 | -25.0% | 0.02% | -25.9% |
Q1 2015 | $619,000 | +8.6% | 40,000 | +11.1% | 0.03% | +35.0% |
Q4 2014 | $570,000 | +52.8% | 36,000 | +2.9% | 0.02% | +122.2% |
Q3 2014 | $373,000 | +58.7% | 35,000 | +40.0% | 0.01% | +80.0% |
Q2 2014 | $235,000 | – | 25,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 726,200 | $3,086,000 | 3.46% |
Paradigm Biocapital Advisors LP | 1,964,709 | $8,350,000 | 1.66% |
683 Capital Management, LLC | 3,300,000 | $14,025,000 | 0.99% |
MAVERICK CAPITAL LTD | 6,747,549 | $28,677,000 | 0.71% |
Antara Capital LP | 1,500,000 | $6,375,000 | 0.27% |
Parkwood LLC | 47,168 | $1,375,000 | 0.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,677,500 | $11,379,000 | 0.24% |
PURA VIDA INVESTMENTS, LLC | 950,813 | $4,041,000 | 0.24% |
OCCUDO QUANTITATIVE STRATEGIES LP | 567,576 | $2,412,000 | 0.20% |
Antara Capital LP | 900,000 | $3,825,000 | 0.16% |